BPI France, alongside Sanofi, Boehringer Ingelheim, Takeda, Ipsen and Servier, have launched InnoBio 2, setting a target of €200-250m and aiming for a first close in September.
Fund, which has already been invested in at least one transaction, has a €1bn target
Pechel, via Pechel IV, and the co-investment team of Omnes back the French IT services firm
Connection Capital provided £6.7m to support the buyout of the business in 2017
Temasek previously led a £7m investment for the technology developer in 2016